Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Hannah Zaryouh"'
Autor:
Hasan Baysal, Vasiliki Siozopoulou, Hannah Zaryouh, Christophe Hermans, Ho Wa Lau, Hilde Lambrechts, Erik Fransen, Ines De Pauw, Julie Jacobs, Marc Peeters, Patrick Pauwels, Jan Baptist Vermorken, Evelien Smits, Filip Lardon, Jorrit De Waele, An Wouters
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous group of tumors that retain their poor prognosis despite recent advances in their standard of care. As the involvement of the immune system against HNSCC development is well-recognized,
Externí odkaz:
https://doaj.org/article/c58e7c1d2db342af9441c51ad1dbe781
Autor:
Hasan Baysal, Ines De Pauw, Hannah Zaryouh, Marc Peeters, Jan Baptist Vermorken, Filip Lardon, Jorrit De Waele, An Wouters
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Cetuximab has an established role in the treatment of patients with recurrent/metastatic colorectal cancer and head and neck squamous cell cancer (HNSCC). However, the long-term effectiveness of cetuximab has been limited by the development of acquir
Externí odkaz:
https://doaj.org/article/3d3269b3d0d44fd38559cddf279054ad
Autor:
Hannah Zaryouh, Ines De Pauw, Hasan Baysal, Patrick Pauwels, Marc Peeters, Jan Baptist Vermorken, Filip Lardon, An Wouters
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The epidermal growth factor receptor (EGFR) is a therapeutic target in head and neck squamous cell carcinoma (HNSCC). Resistance to EGFR-targeted therapies, such as cetuximab, poses a challenging problem. This study aims to characterize acquired cetu
Externí odkaz:
https://doaj.org/article/9c0cba2fff934b7ebc585ed25872b544
Autor:
Jorrit De Waele, Marc Peeters, Evelien Smits, Filip Lardon, Jan B Vermorken, Julie Jacobs, Hasan Baysal, An Wouters, Patrick Pauwels, Hannah Zaryouh, Ines De Pauw
Publikováno v:
British Journal of Cancer
The British journal of cancer
The British journal of cancer
Background The epidermal growth factor receptor (EGFR) is overexpressed by 80–90% of squamous cell carcinoma of head and neck (HNSCC). In addition to inhibiting EGFR signal transduction, cetuximab, a monoclonal antibody targeting EGFR can also bind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2403c8a84d6fd77cb1e7f9db86fcad30
http://europepmc.org/articles/PMC7462851
http://europepmc.org/articles/PMC7462851
Autor:
Hannah Zaryouh, Ines De Pauw, Marc Peeters, Jan B. Vermorken, Hasan Baysal, Filip Lardon, An Wouters
Publikováno v:
Medicinal research reviews
Resistance to therapies targeting the epidermal growth factor receptor (EGFR), such as cetuximab, remains a major roadblock in the search for effective therapeutic strategies in head and neck squamous cell carcinoma (HNSCC). Due to its close interact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeb7b7461bd3cbf687a71ab05dba8c45
https://hdl.handle.net/10067/1782160151162165141
https://hdl.handle.net/10067/1782160151162165141
Autor:
Valentin Van den bossche, Hannah Zaryouh, Marianela Vara-Messler, Julie Vignau, Jean-Pascal Machiels, An Wouters, Sandra Schmitz, Cyril Corbet
Publikováno v:
Drug resistance updates
Squamous cell carcinoma of the head and neck (SCCHN) is among the most prevalent cancer types worldwide. Despite multimodal therapeutic approaches that include surgical resection, radiation therapy or concurrent chemoradiation, targeted therapy and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e76d3dabcc6f4b9e8d641f9a2741f14a
https://pubmed.ncbi.nlm.nih.gov/35121337
https://pubmed.ncbi.nlm.nih.gov/35121337
Autor:
Hannah Zaryouh, Jinthe Van Loenhout, Marc Peeters, Jan Baptist Vermorken, Filip Lardon, An Wouters
Publikováno v:
Cancers
Rmmunity by ensuring the release of antigens, potentially leading to recognition and elimination of the tumor, we believe that it is worth investigating autophagy as an anti-tumor mechanism in HNSCC.Resistance to EGFR-targeted therapy is a major obst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6acf0f0641e3342b56929a81c4ba01bb
https://doi.org/10.3390/cancers14246128
https://doi.org/10.3390/cancers14246128
Autor:
Marc Peeters, Patrick Pauwels, Jan B. Vermorken, Hasan Baysal, Hannah Zaryouh, Ines De Pauw, Filip Lardon, An Wouters
Publikováno v:
Cancer Research. 81:1095-1095
Resistance to therapies targeting the epidermal growth factor receptor (EGFR), such as cetuximab, remains a major roadblock in the search for effective therapeutic strategies in head and neck squamous cell carcinoma (HNSCC). Increasing evidence sugge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e551b2e55414c31354e8c1d90b71cf3
https://doi.org/10.1158/1538-7445.am2021-1095
https://doi.org/10.1158/1538-7445.am2021-1095
Autor:
Marc Peeters, Jan B. Vermorken, Hasan Baysal, Filip Lardon, Evelien Smits, An Wouters, Julie Jacobs, Hannah Zaryouh, Ines De Pauw
Publikováno v:
Cancer Research. 80:3371-3371
The epidermal growth factor receptor (EGFR)-targeted therapies and immunotherapies are now at the forefront for treatment of head and neck squamous cell carcinoma (HNSCC). However, resistance to cetuximab, an anti-EGFR monoclonal antibody (mAb), is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2502d361407638a3d38018495cc2f0e2
https://doi.org/10.1158/1538-7445.am2020-3371
https://doi.org/10.1158/1538-7445.am2020-3371
Autor:
Zaryouh, Hannah1 (AUTHOR) hannah.zaryouh@uantwerpen.be, Van Loenhout, Jinthe1 (AUTHOR), Peeters, Marc1,2 (AUTHOR), Vermorken, Jan Baptist1,2 (AUTHOR), Lardon, Filip1 (AUTHOR), Wouters, An1 (AUTHOR)
Publikováno v:
Cancers. 12/15/2022, Vol. 14 Issue 24, p6128. 10p.